Soros Fund Management’s Bio-Techne TECH Stock Holding History

Soros Fund Management’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$37.8M	Buy	+535,400	New	+$28.9M	0.46%	67
2017 Q3	–	Sell	-8,000	Closed	-$235K	–	267
2017 Q2	$235K	Buy	+8,000	New	+$219K	﹤0.01%	184
2016 Q2	–	Sell	-72,000	Closed	-$1.7M	–	244
2016 Q1	$1.7M	Buy	+72,000	New	+$1.59M	0.04%	143
2015 Q4	–	Sell	-22,000	Closed	-$509K	–	307
2015 Q3	$509K	Buy	+22,000	New	+$552K	0.01%	199

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Soros Fund Management's TECH Position: Q2 2026 in Review

Soros Fund Management opened a new position in Bio-Techne (TECH) in Q2 2026: 535,400 shares worth $37.8M. The stake represents 0.46% of the portfolio and ranks #67 among its holdings. This is a return to the name: Soros Fund Management previously reported a position in TECH as recently as Q2 2017.

Soros Fund Management first reported a position in TECH in Q3 2015 and has held it in 4 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Soros Fund Management held 535,400 shares of Bio-Techne worth $37.8M as of Q2 2026.
Bio-Techne was a new Soros Fund Management position in Q2 2026.
Bio-Techne made up 0.46% of Soros Fund Management's portfolio in Q2 2026, its #67 holding.
Soros Fund Management first reported a position in Bio-Techne in Q3 2015 and has held it in 4 quarters since.
596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Soros Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.